» Articles » PMID: 32932574

Therapeutic Effects of Lactoferrin in Ocular Diseases: From Dry Eye Disease to Infections

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Sep 16
PMID 32932574
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Lactoferrin is a naturally occurring iron-binding glycoprotein, produced and secreted by mucosal epithelial cells and neutrophils in various mammalian species, including humans. It is typically found in fluids like saliva, milk and tears, where it reaches the maximum concentration. Thanks to its unique anti-inflammatory, antioxidant and antimicrobial activities, topical application of lactoferrin plays a crucial role in the maintenance of a healthy ocular surface system. The present review aims to provide a comprehensive evaluation of the clinical applications of lactoferrin in ocular diseases. Besides the well-known antibacterial effect, novel interest has been rising towards its potential application in the field of dry eye and viral infections. A growing body of evidence supports the antimicrobial efficacy of lactoferrin, which is not limited to its iron-chelating properties but also depends on its capability to directly interact with pathogen particles while playing immunomodulatory effects. Nowadays, lactoferrin antiviral activity is of special interest, since lactoferrin-based eye drops could be adopted to treat/prevent the new severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, which has conjunctivitis among its possible clinical manifestations. In the future, further data from randomized controlled studies are desirable to confirm the efficacy of lactoferrin in the wide range of ocular conditions where it can be used.

Citing Articles

Lactoferrin as a Versatile Agent in Nanoparticle Applications: From Therapeutics to Agriculture.

Akdasci E, Eker F, Duman H, Singh P, Bechelany M, Karav S Nanomaterials (Basel). 2024; 14(24.

PMID: 39728554 PMC: 11728633. DOI: 10.3390/nano14242018.


Tear-Based Ocular Wearable Biosensors for Human Health Monitoring.

Rajan A, Vishnu J, Shankar B Biosensors (Basel). 2024; 14(10).

PMID: 39451696 PMC: 11506517. DOI: 10.3390/bios14100483.


Human tear film protein sampling using soft contact lenses.

Roden R, Zuniga N, Wright J, Parkinson D, Jiang F, Patil L Clin Proteomics. 2024; 21(1):23.

PMID: 38481131 PMC: 10936081. DOI: 10.1186/s12014-024-09475-8.


Treatment of Dry Eye Disease (DED) in Asia: Strategies for Short Tear Film Breakup Time-Type DED.

Kawahara A Pharmaceutics. 2023; 15(11).

PMID: 38004570 PMC: 10674215. DOI: 10.3390/pharmaceutics15112591.


Advances in clinical examination of lacrimal gland.

Lin Y, Zhang Y, Shi K, Wu H, Ou S Front Med (Lausanne). 2023; 10:1257209.

PMID: 37720501 PMC: 10501785. DOI: 10.3389/fmed.2023.1257209.


References
1.
Tran M, Lausch R, Oakes J . Substance P differentially stimulates IL-8 synthesis in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2000; 41(12):3871-7. View

2.
Fujihara T, Nagano T, Nakamura M, Shirasawa E . Lactoferrin suppresses loss of corneal epithelial integrity in a rabbit short-term dry eye model. J Ocul Pharmacol Ther. 1998; 14(2):99-107. DOI: 10.1089/jop.1998.14.99. View

3.
Giansanti F, Panella G, Leboffe L, Antonini G . Lactoferrin from Milk: Nutraceutical and Pharmacological Properties. Pharmaceuticals (Basel). 2016; 9(4). PMC: 5198036. DOI: 10.3390/ph9040061. View

4.
Devendra J, Singh S . Effect of Oral Lactoferrin on Cataract Surgery Induced Dry Eye: A Randomised Controlled Trial. J Clin Diagn Res. 2015; 9(10):NC06-9. PMC: 4625269. DOI: 10.7860/JCDR/2015/15797.6670. View

5.
Seganti L, Di Biase A, Rega B, De Giulio B, Nicoletti M, Antonini G . Involvement of bovine lactoferrin moieties in the inhibition of herpes simplex virus type 1 infection. Int J Immunopathol Pharmacol. 2003; 14(2):71-79. View